Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

CNS 4Breast 3Gastrointestinal 2NET 1Gynecologic 1Genitourinary 1Endocrine 1

Conditions

Brain Neoplasms 3Glioma 1

Interventions

Temozolomide 623Radiotherapy 411Bevacizumab 257Magnetic Resonance Spectroscopy 227Cyclophosphamide 179Radiosurgery 163Carboplatin 160Etoposide 132Radiation 129Vincristine 115Irinotecan 115Cisplatin 103Filgrastim 100Specimen Handling 90Nivolumab 88pembrolizumab 84Surgical Procedures, Operative 83Lomustine 83Topotecan 73Doxorubicin 61Melphalan 59Carmustine 57Radiotherapy, Intensity-Modulated 56sargramostim 53Isotretinoin 53Peripheral Blood Stem Cell Transplantation 52Granulocyte Colony-Stimulating Factor 51Chemotherapy, Adjuvant 51Blood Specimen Collection 51Erlotinib Hydrochloride 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
gadoterate meglumine × CNS × Clear all
NCT05937776 2026-06-05

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

OHSU Knight Cancer Institute

Completed
4 enrolled
CNS

Glioma

NCT06057168 2026-01-29

GDX-44-016

Guerbet

Phase 3 Completed
138 enrolled 7 charts
CNS

Brain Neoplasms

NCT03091803 2021-04-05

QSM and Regional DCE MRI Permeability Using GOCART Technique

University of Southern California

Withdrawn
CNS

Brain Neoplasms

NCT02034708 2016-12-30

REMIND

Guerbet

Phase 4 Completed
279 enrolled 9 charts
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡